Recent studies have identified the MD-2/TLR4/NF-κB axis as a key mechanism in HFD- and obesity-related renal damage, suggesting that targeting this pathway may provide a novel approach to mitigating HFD-induced nephropathy [8,30,31,32,33]. The gene discussed is TLR4; the disease is Obesity.